Quarterly report pursuant to Section 13 or 15(d)

Formation and Reverse Acquisition of Matinas Biopharma Holdings - Merger (Details Textual)

v2.4.0.8
Formation and Reverse Acquisition of Matinas Biopharma Holdings - Merger (Details Textual) (USD $)
1 Months Ended 2 Months Ended 1 Months Ended
May 31, 2013
Jul. 31, 2013
Merger [Member]
Jul. 31, 2013
Herbert Conrad [Member]
Aug. 31, 2013
Herbert Conrad [Member]
Jul. 31, 2013
Roelof Rongen [Member]
Jul. 31, 2013
Abdel A Fawzy [Member]
Jul. 31, 2013
George Bobotas And His Spouse [Member]
Jul. 31, 2013
Jerome Jabbour [Member]
Jul. 31, 2013
Stefano Ferrari [Member]
Formation And Reverse Acquisition [Line Items]                  
Stock Issued During Period, Shares, New Issues 7,500,000 9,000,000 351,563   3,417,186 1,708,593 1,366,875 759,374 351,563
Aggregate Common Stock Holding Percentage   28.50%              
Warrants Issued For Purchase Of Common Stock   1,000,000 250,000 250,000         250,000
Investment Warrants, Exercise Price $ 2.00 $ 2.00